company background image
5061

Parnax Lab BSE:506128 Stock Report

Last Price

₹99.20

Market Cap

₹1.1b

7D

5.5%

1Y

284.5%

Updated

17 Aug, 2022

Data

Company Financials
506128 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health2/6
Dividends0/6

506128 Stock Overview

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India.

Parnax Lab Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Parnax Lab
Historical stock prices
Current Share Price₹99.20
52 Week High₹169.90
52 Week Low₹22.00
Beta1.14
1 Month Change11.09%
3 Month Change-22.04%
1 Year Change284.50%
3 Year Change312.47%
5 Year Change77.30%
Change since IPO1,080.95%

Recent News & Updates

Shareholder Returns

506128IN PharmaceuticalsIN Market
7D5.5%0.2%1.9%
1Y284.5%-11.7%9.1%

Return vs Industry: 506128 exceeded the Indian Pharmaceuticals industry which returned -11.7% over the past year.

Return vs Market: 506128 exceeded the Indian Market which returned 9.1% over the past year.

Price Volatility

Is 506128's price volatile compared to industry and market?
506128 volatility
506128 Average Weekly Movement9.0%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 506128 is more volatile than 90% of Indian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: 506128's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
198210Prakash Shahhttps://www.naxparlab.com

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India. It offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. The company also provides cosmetic products; herbal/ayurvedic products; and nutraceutical products.

Parnax Lab Limited Fundamentals Summary

How do Parnax Lab's earnings and revenue compare to its market cap?
506128 fundamental statistics
Market Cap₹1.14b
Earnings (TTM)₹91.98m
Revenue (TTM)₹1.71b

12.4x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
506128 income statement (TTM)
Revenue₹1.71b
Cost of Revenue₹929.90m
Gross Profit₹780.87m
Other Expenses₹688.89m
Earnings₹91.98m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)8.01
Gross Margin45.64%
Net Profit Margin5.38%
Debt/Equity Ratio143.1%

How did 506128 perform over the long term?

See historical performance and comparison